✦ LIBER ✦

Novel 5α-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer

✍ Scribed by Motohide Uemura; Kenji Tamura; Suyoun Chung; Seijiro Honma; Akihiko Okuyama; Yusuke Nakamura; Hidewaki Nakagawa

Book ID: 108584051
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 214 KB
Volume: 0
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2007.00656.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification and characterization of s

Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissue

✍ Makridakis, Nick; Akalu, Abebe; Reichardt, Juergen K V 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

Variation in Genes Encoding the Neuroact

Variation in Genes Encoding the Neuroactive Steroid Synthetic Enzymes 5α-Reductase Type 1 and 3α-Reductase Type 2 Is Associated With Alcohol Dependence

✍ Verica Milivojevic; Henry R. Kranzler; Joel Gelernter; Linda Burian; Jonathan Co 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Impact of genetic polymorphisms of 17-hy

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5α-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population

✍ Yasushi Yamada; Masatoshi Watanabe; Mariko Murata; Mikio Yamanaka; Yoshinobu Kub 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 1 views

Consideration of the use of 17β-N,N-diet

Consideration of the use of 17β-N,N-diethylcarbamoyl-4-methyl-4-aza-5-α-androstan-3-one (4MA), a 5α-reductase inhibitor, in prostate cancer therapy

✍ A. A. Geldof; M. F. A. Meulenbroek; I. Dijkstra; S. Bohlken; B. R. Rao 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 975 KB

The novel heterodinucleoside dimer 5-FdU

The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145

✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell